SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Advaxis, Inc. (ADXS) (CIK 0001100397) — Oct 20, 2021

Advaxis, Inc. (ADXS) (CIK 0001100397)
Date: Oct. 20, 2021 · CIK: 0001100397 · Accession: 0001493152-21-025860

AI Filing Summary & Sentiment

File numbers found in text: 333-259065

Date
Oct. 20, 2021
Author
President
Form
CORRESP
Company
Advaxis, Inc. (ADXS) (CIK 0001100397)

Letter

Division of Corporate Finance Office of Life Sciences Attention: David Gessert VIA EDGAR Re: Advaxis, Inc. Registration Statement on Form S-4 Filed August 25, 2021 File No. 333-259065

Dear Mr. Gessert:

In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of Amendment No. 2 to the Registration Statement on Form S-4 (File No. 333-259065) (the “Registration Statement”) of Advaxis, Inc. We respectfully request that the Registration Statement become effective as of 4:00 p.m., Eastern time, on October 20, 2021, or as soon as practicable thereafter. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Morgan, Lewis & Bockius LLP, by calling Justin W. Chairman at (215) 963-5061 or Emily Drazan Chapman at (202) 739-5699.

Very Truly Yours,
Advaxis, Inc.

Show Raw Text
CORRESP
1
filename1.htm

Advaxis,
Inc.

9
Deer Park Drive, Suite K-1

Monmouth
Junction, NJ 08852

October
20, 2021

U.S.
Securities and Exchange Commission

Division
of Corporate Finance

Office
of Life Sciences

100
F Street NE

Washington,
DC 20549

Attention:
David Gessert

VIA
EDGAR

    Re:
    Advaxis,
    Inc.

    Registration
    Statement on Form S-4

    Filed
    August 25, 2021

    File
    No. 333-259065

Dear
Mr. Gessert:

In
accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby
request acceleration of the effective date of Amendment No. 2 to the Registration Statement on Form S-4 (File No. 333-259065) (the “Registration
Statement”) of Advaxis, Inc. We respectfully request that the Registration Statement become effective as of 4:00 p.m., Eastern
time, on October 20, 2021, or as soon as practicable thereafter. Once the Registration Statement has been declared effective, please
orally confirm that event with our counsel, Morgan, Lewis & Bockius LLP, by calling Justin W. Chairman at (215) 963-5061 or Emily
Drazan Chapman at (202) 739-5699.

    Very Truly Yours,

    Advaxis, Inc.

    By:
    /s/
    Kenneth A. Berlin

    Name:
    Kenneth
    A. Berlin

    Title:
    President
and Chief Executive Officer

    cc:

    Morgan,
    Lewis & Bockius LLP